{"id":381146,"date":"2020-11-13T17:03:05","date_gmt":"2020-11-13T22:03:05","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=381146"},"modified":"2020-11-13T17:03:05","modified_gmt":"2020-11-13T22:03:05","slug":"lexagene-announces-results-of-annual-general-shareholders-meeting","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lexagene-announces-results-of-annual-general-shareholders-meeting\/","title":{"rendered":"LexaGene Announces Results of Annual General Shareholder\u2019s Meeting"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">BEVERLY, Mass., Nov.  13, 2020  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OIVlE6rc_P_VwS7biCpurpvdNDc48xcd_X4hg61lUnRn81bwKD6V9nNuM7I7aUFB1Y-BByuwOkNQ6GGyi07kr6DSMOL9kB9440pEuEpglwA=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">LexaGene Holdings, Inc.<\/a>,\u00a0(<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5yyoRUlxkAfP7Ph9kGclb38PZMpf0l-HJ7hhje3VQpsLP3pGxKcRltsGUuKWOOD08zNXlpusHO7NgZ4ONmnJOH3bBwZaHE1gemDf0FKwWCM=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">TSX-V: LXG<\/a>; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=895k0MVULTGKxSe0lORYxEtIGPY7coCeoPPb9FTAfXQL-fYPuzr0el5M7os5Tc6VYsvZh1y2efIKPZHcUwT7nS2Ngs-HpdXBh3Tqh2aol6Xz3NHzduUBzx-L5AEtNOXW\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">OTCQB: LXXGF<\/a>) (the \u201c<strong>Company<\/strong>\u201d), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is pleased to announce the voting results of the Company\u2019s 2020 Annual General Shareholder\u2019s Meeting held on November 10, 2020 in Vancouver, British Columbia.<\/p>\n<p>A total of 48,273,080 common shares were voted at the Meeting, representing 42.26% of the votes attached to all outstanding common shares of the Company.<\/p>\n<p>All matters presented for shareholder approval at the Meeting were duly authorized and approved as follows:<\/p>\n<ul type=\"disc\">\n<li>To set the number of Directors to be elected at five.<\/li>\n<li>Election of Directors.<\/li>\n<li>To re-appoint Manning Elliot LLP, Chartered Professional Accountants as the Company\u2019s auditors for the ensuing year.<\/li>\n<li>Increase the number of Common Shares available for conversion of Restricted Share Units.<\/li>\n<li>Increase the number of Common Shares available for exercise of Options.\n<\/li>\n<\/ul>\n<p>Detailed voting results for the election of directors were as follows:<\/p>\n<table style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:20%;width:20%;min-width:20%;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>Name<\/strong>\n          <\/td>\n<td style=\"max-width:20%;width:20%;min-width:20%;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>Shares Voted For<\/strong>\n          <\/td>\n<td style=\"max-width:20%;width:20%;min-width:20%;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>%<\/strong>\n          <\/td>\n<td style=\"max-width:20%;width:20%;min-width:20%;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>Shares Withheld \/ <br \/>Abstain<\/strong>\n          <\/td>\n<td style=\"max-width:20%;width:20%;min-width:20%;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>%<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Dr. John (Jack) Regan<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top;text-align: center;vertical-align: middle\">22,117,120<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top;text-align: center;vertical-align: middle\">97.03<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top;text-align: center;vertical-align: middle\">677,427<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top;text-align: center;vertical-align: middle\">2.97<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Daryl Rebeck<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top;text-align: center;vertical-align: middle\">22,705,522<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top;text-align: center;vertical-align: middle\">95.22<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top;text-align: center;vertical-align: middle\">1,089,025<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top;text-align: center;vertical-align: middle\">4.78<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Thomas Richard Slezak<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top;text-align: center;vertical-align: middle\">22,691,362<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top;text-align: center;vertical-align: middle\">99.55<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top;text-align: center;vertical-align: middle\">103,185<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top;text-align: center;vertical-align: middle\">0.45<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Dr. Manohar Furtado<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top;text-align: center;vertical-align: middle\">22,717,615<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top;text-align: center;vertical-align: middle\">99.66<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top;text-align: center;vertical-align: middle\">76,932<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top;text-align: center;vertical-align: middle\">0.34<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Joseph Caruso<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top;text-align: center;vertical-align: middle\">22,494,351<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top;text-align: center;vertical-align: middle\">98.68<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top;text-align: center;vertical-align: middle\">300,196<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top;text-align: center;vertical-align: middle\">1.32<\/td>\n<\/tr>\n<\/table>\n<p>To be added to the LexaGene email list, please subscribe on the Company <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SZ2JWHYP0znBf09LjWL5cUo5__uxcbyiGFJzrPn11VVwIVb7R82By3uHMnfw8oUP44FE9ldmGM3EtdV57NP9Hg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">website<\/a>.<\/p>\n<p>\n        <strong>On Behalf of the Board of Directors<\/strong><br \/>\n        <br \/>\n        <strong>Dr. Jack Regan<\/strong><br \/>\n        <br \/>\n        <strong>Chief Executive Officer<\/strong><br \/>\n        <strong> &amp; Director<\/strong>\n      <\/p>\n<p>\n        <strong>About LexaGene Holdings Inc.<\/strong><br \/>\n        <br \/>LexaGene is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, food safety and for use in open-access markets such as clinical research, agricultural testing and biodefense. End-users simply need to collect a sample, load it onto the instrument with a sample preparation cartridge, enter sample ID and press \u2018go\u2019. The MiQLab\u2122 system delivers excellent sensitivity, specificity, and breadth of detection and can return results in approximately one hour. The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.<\/p>\n<p>\n        <strong>For further information, please contact:<\/strong>\n      <\/p>\n<p>\n        <strong>Media Contacts<\/strong><br \/>\n        <br \/>Nicole Ridgedale<br \/>Director of Corporate Marketing, LexaGene<br \/>800.215.1824 ext 206<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wLzGJoCeW67CtVF6uZ_2ES2DI2yGBygeGUfcztn77YCikZcLLGeTPSkLRmdtHVAIh7zcbBykv4Hq2QqJFwOYL9rtsPRo-R_zQzbIcI0_Op8=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">nridgedale@lexagene.com<\/a><\/p>\n<p>\n        <strong>Investor Relations<\/strong><br \/>\n        <br \/>Jay Adelaar<br \/>Vice President of Capital Markets, LexaGene<br \/>800.215.1824 ext 207<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YJByc6gXDBF1_w0OCN8LpX6Lnt7k5eHd13Yc7-DwRWXeqLXVkn-fH5tyUQEh2Nd7n_o9Pk5WjFDK1QRGO-RlIPD4ulMfZKqOpfK1CKMlWio=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">jadelaar@lexagene.com<\/a><\/p>\n<p align=\"justify\">\n        <em>The TSX Venture Exchange Inc. has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.<\/em>\n      <\/p>\n<p>\n        <em>This news release contains forward-looking information, which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectation. Important factors &#8212; including the availability of funds, the results of financing efforts, the success of technology development efforts, the cost to procure critical parts, performance of the instrument, market acceptance of the technology, regulatory acceptance, and licensing issues &#8212; that could cause actual results to differ materially from the Company&#8217;s expectations as disclosed in the Company&#8217;s documents filed from time to time on SEDAR (see\u00a0<\/em><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DrjxQIbFFmpvYutBQlIZYL5bix1MBKNx_hly4RnjyOB0niM2wgHNFvuxnGziOVv1gl-EpsZ6nDRqa5sncniQTQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><br \/>\n          <em>www.sedar.com<\/em><br \/>\n        <\/a><br \/>\n        <em>). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.<\/em>\n      <\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTg0OCMzODI2NTAwIzIwODM5NjI=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/064a4d00-d02a-4394-843f-a49a576b74fa\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BEVERLY, Mass., Nov. 13, 2020 (GLOBE NEWSWIRE) &#8212; LexaGene Holdings, Inc.,\u00a0(TSX-V: LXG; OTCQB: LXXGF) (the \u201cCompany\u201d), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is pleased to announce the voting results of the Company\u2019s 2020 Annual General Shareholder\u2019s Meeting held on November 10, 2020 in Vancouver, British Columbia. A total of 48,273,080 common shares were voted at the Meeting, representing 42.26% of the votes attached to all outstanding common shares of the Company. All matters presented for shareholder approval at the Meeting were duly authorized and approved as follows: To set the number of Directors to be elected at five. Election of Directors. To re-appoint Manning Elliot LLP, Chartered Professional Accountants as the Company\u2019s auditors for &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lexagene-announces-results-of-annual-general-shareholders-meeting\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;LexaGene Announces Results of Annual General Shareholder\u2019s Meeting&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-381146","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>LexaGene Announces Results of Annual General Shareholder\u2019s Meeting - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lexagene-announces-results-of-annual-general-shareholders-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LexaGene Announces Results of Annual General Shareholder\u2019s Meeting - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BEVERLY, Mass., Nov. 13, 2020 (GLOBE NEWSWIRE) &#8212; LexaGene Holdings, Inc.,\u00a0(TSX-V: LXG; OTCQB: LXXGF) (the \u201cCompany\u201d), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is pleased to announce the voting results of the Company\u2019s 2020 Annual General Shareholder\u2019s Meeting held on November 10, 2020 in Vancouver, British Columbia. A total of 48,273,080 common shares were voted at the Meeting, representing 42.26% of the votes attached to all outstanding common shares of the Company. All matters presented for shareholder approval at the Meeting were duly authorized and approved as follows: To set the number of Directors to be elected at five. Election of Directors. To re-appoint Manning Elliot LLP, Chartered Professional Accountants as the Company\u2019s auditors for &hellip; Continue reading &quot;LexaGene Announces Results of Annual General Shareholder\u2019s Meeting&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lexagene-announces-results-of-annual-general-shareholders-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-13T22:03:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTg0OCMzODI2NTAwIzIwODM5NjI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexagene-announces-results-of-annual-general-shareholders-meeting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexagene-announces-results-of-annual-general-shareholders-meeting\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"LexaGene Announces Results of Annual General Shareholder\u2019s Meeting\",\"datePublished\":\"2020-11-13T22:03:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexagene-announces-results-of-annual-general-shareholders-meeting\\\/\"},\"wordCount\":575,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexagene-announces-results-of-annual-general-shareholders-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NTg0OCMzODI2NTAwIzIwODM5NjI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexagene-announces-results-of-annual-general-shareholders-meeting\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexagene-announces-results-of-annual-general-shareholders-meeting\\\/\",\"name\":\"LexaGene Announces Results of Annual General Shareholder\u2019s Meeting - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexagene-announces-results-of-annual-general-shareholders-meeting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexagene-announces-results-of-annual-general-shareholders-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NTg0OCMzODI2NTAwIzIwODM5NjI=\",\"datePublished\":\"2020-11-13T22:03:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexagene-announces-results-of-annual-general-shareholders-meeting\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexagene-announces-results-of-annual-general-shareholders-meeting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexagene-announces-results-of-annual-general-shareholders-meeting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NTg0OCMzODI2NTAwIzIwODM5NjI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NTg0OCMzODI2NTAwIzIwODM5NjI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexagene-announces-results-of-annual-general-shareholders-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LexaGene Announces Results of Annual General Shareholder\u2019s Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"LexaGene Announces Results of Annual General Shareholder\u2019s Meeting - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lexagene-announces-results-of-annual-general-shareholders-meeting\/","og_locale":"en_US","og_type":"article","og_title":"LexaGene Announces Results of Annual General Shareholder\u2019s Meeting - Market Newsdesk","og_description":"BEVERLY, Mass., Nov. 13, 2020 (GLOBE NEWSWIRE) &#8212; LexaGene Holdings, Inc.,\u00a0(TSX-V: LXG; OTCQB: LXXGF) (the \u201cCompany\u201d), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is pleased to announce the voting results of the Company\u2019s 2020 Annual General Shareholder\u2019s Meeting held on November 10, 2020 in Vancouver, British Columbia. A total of 48,273,080 common shares were voted at the Meeting, representing 42.26% of the votes attached to all outstanding common shares of the Company. All matters presented for shareholder approval at the Meeting were duly authorized and approved as follows: To set the number of Directors to be elected at five. Election of Directors. To re-appoint Manning Elliot LLP, Chartered Professional Accountants as the Company\u2019s auditors for &hellip; Continue reading \"LexaGene Announces Results of Annual General Shareholder\u2019s Meeting\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lexagene-announces-results-of-annual-general-shareholders-meeting\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-13T22:03:05+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTg0OCMzODI2NTAwIzIwODM5NjI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexagene-announces-results-of-annual-general-shareholders-meeting\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexagene-announces-results-of-annual-general-shareholders-meeting\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"LexaGene Announces Results of Annual General Shareholder\u2019s Meeting","datePublished":"2020-11-13T22:03:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexagene-announces-results-of-annual-general-shareholders-meeting\/"},"wordCount":575,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexagene-announces-results-of-annual-general-shareholders-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTg0OCMzODI2NTAwIzIwODM5NjI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexagene-announces-results-of-annual-general-shareholders-meeting\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lexagene-announces-results-of-annual-general-shareholders-meeting\/","name":"LexaGene Announces Results of Annual General Shareholder\u2019s Meeting - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexagene-announces-results-of-annual-general-shareholders-meeting\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexagene-announces-results-of-annual-general-shareholders-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTg0OCMzODI2NTAwIzIwODM5NjI=","datePublished":"2020-11-13T22:03:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexagene-announces-results-of-annual-general-shareholders-meeting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lexagene-announces-results-of-annual-general-shareholders-meeting\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexagene-announces-results-of-annual-general-shareholders-meeting\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTg0OCMzODI2NTAwIzIwODM5NjI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTg0OCMzODI2NTAwIzIwODM5NjI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexagene-announces-results-of-annual-general-shareholders-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"LexaGene Announces Results of Annual General Shareholder\u2019s Meeting"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/381146","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=381146"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/381146\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=381146"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=381146"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=381146"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}